These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 24449235)
1. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235 [TBL] [Abstract][Full Text] [Related]
2. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862 [TBL] [Abstract][Full Text] [Related]
3. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308 [TBL] [Abstract][Full Text] [Related]
4. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848 [TBL] [Abstract][Full Text] [Related]
5. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling. Peshkin BN; Kelly S; Nusbaum RH; Similuk M; DeMarco TA; Hooker GW; Valdimarsdottir HB; Forman AD; Joines JR; Davis C; McCormick SR; McKinnon W; Graves KD; Isaacs C; Garber J; Wood M; Jandorf L; Schwartz MD J Genet Couns; 2016 Jun; 25(3):472-82. PubMed ID: 26455498 [TBL] [Abstract][Full Text] [Related]
6. Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up. Interrante MK; Segal H; Peshkin BN; Valdimarsdottir HB; Nusbaum R; Similuk M; DeMarco T; Hooker G; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Heinzmann J; Kinney AY; Schwartz MD JNCI Cancer Spectr; 2017 Sep; 1(1):pkx002. PubMed ID: 31304457 [TBL] [Abstract][Full Text] [Related]
7. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Steffen LE; Du R; Gammon A; Mandelblatt JS; Kohlmann WK; Lee JH; Buys SS; Stroup AM; Campo RA; Flores KG; Vicuña B; Schwartz MD; Kinney AY Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1772-1780. PubMed ID: 28971986 [No Abstract] [Full Text] [Related]
8. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250 [TBL] [Abstract][Full Text] [Related]
9. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review. Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837 [TBL] [Abstract][Full Text] [Related]
12. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342 [TBL] [Abstract][Full Text] [Related]
13. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling. Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464 [TBL] [Abstract][Full Text] [Related]
14. Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Butrick M; Kelly S; Peshkin BN; Luta G; Nusbaum R; Hooker GW; Graves K; Feeley L; Isaacs C; Valdimarsdottir HB; Jandorf L; DeMarco T; Wood M; McKinnon W; Garber J; McCormick SR; Schwartz MD Genet Med; 2015 Jun; 17(6):467-75. PubMed ID: 25232856 [TBL] [Abstract][Full Text] [Related]
15. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322 [TBL] [Abstract][Full Text] [Related]
16. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial. Quinn VF; Meiser B; Kirk J; Tucker KM; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Cicciarelli L; Crowe K; Bowen MT; Mitchell G Genet Med; 2017 Apr; 19(4):448-456. PubMed ID: 27684037 [TBL] [Abstract][Full Text] [Related]